Compared with the expression levels in the tumor‐free control, metastatic progression of B16F10 cells led to HPK1 upregulation in splenic NK cells at the protein level, as determined by flow cytometry (Figure 1h) and Western blot analysis (Figure 1i). Here, MAP4K1 is linked to neoplasm.